Featured News

A recent international study co-authored by Celiac Disease Foundation grant award winner Dr. Benjamin Lebwohl aimed to assess the effectiveness of the Pfizer COVID-19 vaccine in patients with celiac disease. Results revealed that the Pfizer COVID-19 vaccine offers the same level of protection against the virus for patients with celiac disease as it does for those without the autoimmune disease.

This October the Celiac Disease Foundation hosted physicians and healthcare representatives from more than 15 hospitals for a gluten-free meal to celebrate researchers and officers of NASPGHAN’s Celiac Special Interest Group and the important work they do through their care for our patient community.

A recent study published in The Lancet Journal of Gastroenterology & Hepatology sought to determine the accuracy of blood (serological) tests in celiac disease diagnosis in adults. The results of this study are interesting, to say the least.

For those in our patient community interested in doing a deeper dive on the topic of celiac disease diagnosis, we are happy to provide here expert commentary from Dr. Robert Anderson, MB ChB PhD, on Ciacci et al. 

The Cribsiders Podcast on pediatric medicine recently released an episode with a special guest, Dr. Dale Lee from Seattle Children's Hospital, about the diagnosis and management of celiac disease.

A recent study evaluated the prevalence of detectable gluten immunogenic peptides (GIPs), which are resistant to digestion and are excreted through the stool and urine, to gauge accidental gluten exposure and adherence to a gluten-free diet in children with celiac disease in the United States.   

Celiac disease world expert Alessio Fasano, MD, recently wrote a commentary on a study that set out to identify a link between inflammatory bowel disease and celiac disease/celiac autoimmunity in children and adults.   

The Celiac Disease Foundation, a trusted partner in optimizing patient recruitment and retention, announces the launch of its iRecruitCeliac platform, which brings together solutions to accelerate enrollment in clinical trials for celiac disease and comorbid conditions.

The Celiac Disease Foundation is proud to continue our partnership with the Celiac Disease Center at Columbia University in presenting an annual free livestream international symposium, this year titled “Celiac Disease: On the Horizon”. Recording available now.

An international study exploring the molecular characteristics of celiac disease identified several genes highly associated with the disease. This new study uncovered that these genes play a pivotal role in regulating celiac disease’s immune response.